Short Interest in iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) Decreases By 56.3%

iShares Neuroscience and Healthcare ETF (NYSEARCA:IBRN) was the target of a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 3,452 shares, a decrease of 56.3% from the July 30th total of 7,895 shares. Based on an average daily trading volume, of 4,508 shares, the days-to-cover ratio is presently 0.8 days. Approximately 2.3% of the company’s stock are short sold.

iShares Neuroscience and Healthcare ETF Stock Performance

IBRN stock remained flat at $39.23 during trading on Monday. 4,007 shares of the company were exchanged, compared to its average volume of 2,328. The business has a fifty day simple moving average of $38.54 and a 200-day simple moving average of $35.31. The firm has a market cap of $5.88 million, a P/E ratio of 15.61 and a beta of 0.75. iShares Neuroscience and Healthcare ETF has a one year low of $25.00 and a one year high of $43.01.

About iShares Neuroscience and Healthcare ETF

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is managed by BlackRock.